Ascent Capital (India)
Ascent Capital is an India-focused growth-equity manager that partners with established businesses at scaling inflection points. Its public record spans technology, consumer, healthcare and financial-services investments, supported by a long-term operating and governance-oriented approach.
At a glance
- Founded
- 2008
- Footprint
- Bengaluru, India
- Stage
- India-focused growth equity; expansion capital and significant-minority investments
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Ascent Capital (India) uses a india-focused growth equity; expansion capital and significant-minority investments approach across Technology, consumer, healthcare, financial services.
Current evidence
Ascent's 2025 impact-report communication covers progress from 2023–2025, including Naari Pharma, and the manager's current communications document a majority investment in Pivot Path, a business carved out of Strides Pharma Science.
Strategy
India-focused growth equity; expansion capital and significant-minority investments
Sector focus
Technology, consumer, healthcare, financial services
Current signal
Ascent's 2025 impact-report communication covers progress from 2023–2025, including Naari Pharma, and the manager's current communications document a majority investment in Pivot Path, a business carved out of Strides Pharma Science.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.